自体血光量子疗法治疗支气管哮喘的临床研究

THE THERAPECTIC EFFECT OF ULTRAVIOLET DLOOD IRRADIATION IN ASTHMATIC ATTACK

近年来自体血光量子疗法(自体血紫外线照射回输疗法UBI)治疗某些疾病有明显疗效,引起国内研究者的关注。为进一步探讨UBI在内科疾病领域中的应用,本文用此疗法治疗13例急性发作期支气管哮喘,并与同期住院本病急性发作期患者8例未采用本疗法进行比较,以期对UBI治疗支气管哮喘的疗效做出评价。 材料和方法 一、对象 本文观察的21例支气管哮喘(急性发作期)均为我科住院病人,全部病例符合全国肺心病会议制定支气管哮喘诊断标准。分为治疗组13例及对照组8例。 二、方法 1.自血光量子疗法组(治疗组):13例患者均经各种平喘药及激素治疗后,哮喘仍反复发作者。其中2例哮喘持续状态,2例呼吸衰竭。其方法是取静脉血200ml。

Thirteen cases of acute asthmatic attack were treated with ultraviolet blood irradia-tiou(UBI). Clinical observation showed that symptoms were well controlled in 92% (12/13) and pulmonary function got improved in 100%. It was also found that the level of plasma middle molecular substances of all patients was decreased obviously after treatment with UBI. The mechanism of the effect of UBI on asthma attack was discussed in this paper. It is possible that high level plasma middle molecular substances may have played a role in occurance and development of asthma by inhibiting activity of adenyl cyclase and blocking β-adrenergic receptor on bronchus and UBI can remove plasma middle molecular substances of patient with asthma, so that UBI can be used to treat acute asthmatic attack.